Abstract
Pulmonary infections are caused by a wide range of pathogenic microorganisms, including bacteria, viruses, fungi, and parasites. The most common lung infections in immunocompetent hosts are caused by pyogenic bacteria (e.g., Streptococcus pneumoniae), common respiratory viruses, and mycoplasma. These infections are usually diagnosed by clinical and microbiologic studies, including cultures and serology tests. Lung biopsy is rarely used in these diagnoses. Patients with life-threatening pneumonia, especially those who are immunocompromised, are more likely to undergo lung biopsy to rule out unusual infections not easily diagnosed using conventional microbiologic methods and for which treatment strategies may be different. Pathogens more likely to be diagnosed using lung biopsy for which there are characteristic pathologic changes are highlighted in this chapter and listed in Table 4.1.
You have full access to this open access chapter, Download chapter PDF
Similar content being viewed by others
Keywords
- Acute bronchopneumonia
- Nocardiosis
- Malakoplakia
- Tuberculosis
- Viral pneumonia
- Fungal pneumonia
- Pneumocystis pneumonia
- Parasitic infestation
Pulmonary infections are caused by a wide range of pathogenic microorganisms, including bacteria, viruses, fungi, and parasites. The most common lung infections in immunocompetent hosts are caused by pyogenic bacteria (e.g., Streptococcus pneumoniae), common respiratory viruses, and mycoplasma. These infections are usually diagnosed by clinical and microbiologic studies, including cultures and serology tests. Lung biopsy is rarely used in these diagnoses. Patients with life-threatening pneumonia, especially those who are immunocompromised, are more likely to undergo lung biopsy to rule out unusual infections not easily diagnosed using conventional microbiologic methods and for which treatment strategies may be different. Pathogens more likely to be diagnosed using lung biopsy for which there are characteristic pathologic changes are highlighted in this chapter and listed in Table 4.1.
Bacterial Pneumonia
Acute bronchopneumonia (Figs. 4.1, 4.2 and 4.3) is caused by various gram-positive or gram-negative bacteria that are sometimes visible on a Gomori methenamine silver (GMS) stain. Bacterial identification using tissue gram stains has low sensitivity and specificity and is neither necessary nor possible in most cases.
Legionnaires’ disease (Fig. 4.4) is an acute bronchopneumonia often characterized by prominent necrosis, karyorrhexis, and histiocyte-rich fibrinous exudates. Special stains are of limited value in identifying the gram-negative bacillus responsible for Legionnaires’ disease and have been largely supplanted by a combination of cultures and serology.
Nocardiosis (Fig. 4.5) occurs almost exclusively in immunocompromised patients and is caused by a gram-positive filamentous organism (Nocardia spp.) common in soil and as normal oral microflora. Nocardia pneumonia may follow a fulminant course, and about half of patients develop disseminated infections, which frequently involve the central nervous system. Actinomycosis (Fig. 4.6) is also caused by gram-positive, anaerobic, filamentous bacteria (Actinomyces spp.) common in the oral cavity and oropharynx. Actinomycosis often occurs in patients with poor oral and dental hygiene. Lung involvement frequently includes fistulous involvement of pleural and chest wall soft tissues. Microscopically, the histologic findings are similar to those described in nocardiosis, but the organisms have a propensity to form larger macroscopic colonies in vivo that are identifiable in routinely stained sections as sulfur granules; these are indistinguishable from those seen more commonly in tonsils.
Rhodococcus equi pneumonia (malakoplakia ) (Fig. 4.7) is caused by a gram-positive bacillus commonly found in soil. Pulmonary infection occurs primarily in immunocompromised patients, most commonly in AIDS patients but also in other immunocompromised populations and occasionally in immunocompetent adults. The histologic findings unique to malakoplakia are the key to establishing the diagnosis in biopsy specimens.
Mycobacterial Disease (Figs. 4.8, 4.9, 4.10, 4.11, 4.12 and 4.13)
The prevalence of Mycobacterium tuberculosis infection (tuberculosis) is low in the United States. Incident cases have fallen dramatically, and most newly diagnosed cases represent reactivation disease in immigrants who acquired the infection elsewhere. Most cases are diagnosed clinically by means of skin tests, cultures, and other laboratory tests. Occasionally, tuberculosis manifesting as a solitary lung nodule or miliary lesions may be biopsied or resected owing to a preoperative concern for malignancy.
Atypical/nontuberculous mycobacterial infections of the lung (Figs. 4.11, 4.12 and 4.13) commonly resemble tuberculosis in terms of clinical presentations and patterns of disease in both immunocompetent and immunocompromised hosts. Definitive diagnosis relies on culture and molecular techniques. Mycobacterium avium complex (MAC) is the most commonly encountered nontuberculous mycobacterium. In addition to causing patterns of disease resembling those seen in tuberculosis, MAC also causes a hypersensitivity pneumonia-like syndrome resulting from sensitization to contaminated hot tubs (“hot-tub lung”).
Viral Pneumonia
Viral pneumonia is common, especially in immunocompromised patients. Some viral infections cause unique cytopathic changes that can be identified on routinely stained sections (Figs. 4.14, 4.15, 4.16, 4.17, 4.18, 4.19 and 4.20). Immunohistochemical staining with specific antibodies is helpful in identifying some of the viruses with overlapping histologic features with greater confidence.
Fungal Pneumonia
The types of fungal infections encountered in lung biopsies or surgical lung specimens are heavily dependent on whether the patient is immunocompetent or immunocompromised. Fungal infections more commonly seen in immunologically intact hosts may also occur in immunocompromised patients in whom the histologic findings may be more variable. Histoplasmosis, blastomycosis, cryptococcosis, and coccidioidomycosis are the fungal infections likely to be encountered in lung biopsies from immunocompetent hosts living in North America. Other fungal diseases are seen almost exclusively in immunocompromised patients.
Histoplasmosis
Histoplasmosis (Figs. 4.21, 4.22, 4.23, 4.24) is endemic in the Mississippi and Ohio River valleys of the United States. The disease is usually asymptomatic and self-limited but may cause a persistent lung nodule that leads to a needle biopsy or excision of the lesion. Necrotizing granulomatous inflammation is the usual finding, except for disseminated histoplasmosis, which is an uncommon form of the disease seen more often in immunocompromised patients.
Blastomycosis
Blastomycosis (Figs. 4.25, 4.26 and 4.27), also termed North American blastomycosis , is caused by Blastomyces dermatitidis and is endemic in the south and central United States. Blastomycosis occurs in both immunocompetent and immunocompromised patients. Like other endemic fungal diseases included in this section, blastomycosis has several different clinical phenotypes that extend to involvement of extrapulmonary sites, primarily the skin. Asymptomatic disease is less common compared to histoplasmosis. Yeast forms are morphologically characteristic and are visible on H&E-stained sections.
Cryptococcosis
Cryptococcosis (Figs. 4.28, 4.29, 4.30 and 4.31) may affect immunocompetent hosts, but symptomatic disease occurs more commonly in patients who are immunocompromised or have other underlying comorbidities. Cryptococcus neoformans has a worldwide distribution with no geographically defined variation in incidence. Patients with cryptococcal infections may be asymptomatic or may have a range of respiratory syndromes, including a subset with isolated lung nodules and ipsilateral nodal disease mimicking tuberculosis or histoplasmosis. In its classic form, Cryptococcus neoformans is distinguished by a mucicarminophilic capsule, but capsule-deficient strains lack this feature.
Coccidioidomycosis
Coccidioidomycosis (Figs. 4.32, 4.33, 4.34 and 4.35) is endemic in the southwestern United States and is caused by the dimorphic fungi Coccidioides immitis and Coccidioides posadasii. It causes disease in both immunocompetent and immunocompromised patients and may be biopsied or excised because of its tendency to form a localized lung nodule. The organism divides by a process of endosporulation, a feature helpful in identifying Coccidioides in routinely and specially stained sections. The mycelial form is much less commonly found in surgical lung specimens.
Aspergillus Infections
Aspergillus infections (Figs. 4.36, 4.37, 4.38, 4.39, 4.40 and 4.41) in the lungs can be noninvasive or invasive. The commonly recognized forms include noninvasive mycetoma or Aspergillus fungus ball, allergic bronchopulmonary aspergillosis (ABPA), invasive Aspergillus pneumonia, and necrotizing tracheobronchitis. Aspergillomas form in immunocompetent patients with underlying cavitary or cystic lung disease. ABPA affects patients with asthma or cystic fibrosis, and invasive forms of the disease occur in immunocompromised patients. Chronic cavitary aspergillosis is a progressive form of disease that has features intermediate between noninvasive and invasive forms of aspergillosis. It is characterized by radiologic progression and tends to occur in patients with underlying comorbidities, particularly chronic lung disease.
Invasive Mucormycosis
Invasive mucormycosis (Figs. 4.42 and 4.43) is caused by a group of fungi referred to as mucormycetes, also referred to as Mucoromycotina or Zygomycota (zygomycetes). Mucormycosis occurs almost exclusively in immunocompromised patients and frequently involves the lungs. Given the high mortality rate, frozen sections are sometimes requested in order to make a rapid diagnosis and promptly start antifungal therapy.
Candidiasis
Candidiasis (Figs. 4.44 and 4.45) is rare and occurs primarily in immunocompromised hosts, usually presenting as angioinvasive disease with necrotizing acute bronchopneumonia and abscess formation. Occasionally, candidiasis is more exquisitely localized to blood vessels (intravascular candidiasis). Rarely, the disease is associated with granulomatous inflammation, mainly in patients with underlying chronic granulomatous disease.
Pneumocystis Pneumonia
Pneumocystis pneumonia (Figs. 4.46, 4.47, 4.48, 4.49 and 4.50) occurs exclusively in immunocompromised patients. The organism Pneumocystis jirovecii was historically considered a protozoon but was reclassified as a fungus on the basis of molecular evidence demonstrating its close relationship to fungi. Pneumocystis pneumonia is affiliated with highly variable histologic features and therefore should always be in the differential diagnosis of infections in immunocompromised patients. In its most classic form, the organisms cluster within a fibrinous air-space exudate, producing a characteristic frothy or bubbly appearance on routinely stained sections. Other relatively common variants include granulomatous inflammation and diffuse alveolar damage.
Suggested Reading
El-Zammar OA, Katzenstein AL. Pathological diagnosis of granulomatous lung disease: a review. Histopathology. 2007;50:289–310.
Gill JR, Sheng ZM, Ely SF, Guinee DG, Beasley MB, Suh J, et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med. 2010;134:235–43.
Hartel PH, Shilo K, Klassen-Fischer M, Neafie RC, Ozbudak IH, Galvin JR, et al. Granulomatous reaction to Pneumocystis jirovecii: clinicopathologic review of 20 cases. Am J Surg Pathol. 2010;34:730–4.
Katzenstein A. Unusual pneumonias and granulomatous infections. In:Katzenstein and Askin’s surgical pathology of non-neoplastic lung disease. 4th ed. Philadelphia: Elsevier; 2006. p. 261–350.
Kwon KY, Colby TV. Rhodococcus equi pneumonia and pulmonary malakoplakia in acquired immunodeficiency syndrome. Pathologic features. Arch Pathol Lab Med. 1994;118:744–8.
Oddo D, Gonzalez S. Actinomycosis and nocardiosis. A morphologic study of 17 cases. Pathol Res Pract. 1986;181:320–6.
Sangoi AR, Rogers WM, Longacre TA, Montoya JG, Baron EJ, Banaei N. Challenges and pitfalls of morphologic identification of fungal infections in histologic and cytologic specimens: a ten-year retrospective review at a single institution. Am J Clin Pathol. 2009;131:364–75.
Travis WD, Pittaluga S, Lipschik GY, Ognibene FP, Suffredini AF, Masur H, et al. Atypical pathologic manifestations of Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome. Review of 123 lung biopsies from 76 patients with emphasis on cysts, vascular invasion, vasculitis, and granulomas. Am J Surg Pathol. 1990;14:615–25.
Winn WC Jr, Myerowitz RL. The pathology of the legionella pneumonias. A review of 74 cases and the literature. Hum Pathol. 1981;12:401–22.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this chapter
Cite this chapter
Zhang, C., Myers, J.L. (2018). Infectious Diseases. In: Zhang, C., Myers, J. (eds) Atlas of Lung Pathology. Atlas of Anatomic Pathology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-8689-7_4
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8689-7_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-8687-3
Online ISBN: 978-1-4939-8689-7
eBook Packages: MedicineMedicine (R0)